Sarosh Rana to Cost-Benefit Analysis
This is a "connection" page, showing publications Sarosh Rana has written about Cost-Benefit Analysis.
Connection Strength
0.330
-
Neonatal cost savings in hypertensive disorders of pregnancy: Economic evaluation of the sFlt-1/PlGF test with real world implementation of biomarkers. Pregnancy Hypertens. 2025 Mar; 39:101190.
Score: 0.183
-
Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States. Pregnancy Hypertens. 2021 Dec; 26:121-126.
Score: 0.147